+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia

Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia

Hypertension 50(1): E3; Author Reply E4-E3; Author Reply E4

In epithelia, junction proteins are endocytosed for modulation of cell-cell adhesion and cell polarity. In response to growth factors, the cell-cell adhesion protein E-cadherin is internalized from the cell surface with degradation or recycling as potential fates. However, the cellular machinery involved in cadherin internalization and recycling remains controversial. Here we investigated EGF-induced E-cadherin internalization.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 016830982

Download citation: RISBibTeXText

PMID: 17502488

DOI: 10.1161/hypertensionaha.107.091421

Related references

Response to questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia: There is no single universal preeclampsia cause. Hypertension (Baltimore) 50(1): E4, 2007

Progress toward identifying potential markers for preeclampsia: role of agonistic autoantibody to the angiotensin II type I receptor. Hypertension 55(2): 236-237, 2010

Angiotensin-1 receptor autoantibodies: A role in the pathogenesis of preeclampsia?. Circulation 101(20): 2335-2337, 2000

The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. American Journal of Obstetrics & Gynecology 178(6): 1307, 1998

Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. Journal of Hypertension 26(7): 1379-1389, 2008

Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50(2): 269-275, 2007

Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia. Journal of Hypertension 33(5): 1046-1056, 2015

Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension 60(3): 712-721, 2012

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 55(2): 386-393, 2010

Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia. Journal of the American Heart Association 4(12):, 2015

Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?. Gynecologic and Obstetric Investigation 81(1): 28-33, 2016

Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 55(5): 1246-1253, 2010

Influence of Angiotensin II Subtype 2 Receptor (AT(2)R) Antagonist, PD123319, on Cardiovascular Remodelling of Aged Spontaneously Hypertensive Rats during Chronic Angiotensin II Subtype 1 Receptor (AT(1)R) Blockade. International Journal of Hypertension 2012: 543062, 2012

Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia. Circulation 121(3): 436-444, 2010